The Wall Street Journal has written about a new initiative begun by Andy Grove with two leading Bay Area universities in medical research and engineering. Responding to Andy’s challenge, UC San Francisco is collaborating with the University of California at Berkeley to offer a two-year master’s degree in “translational medicine,” the discipline of transferring lab breakthroughs to the marketplace. The MBA-style program, which Andy helped establish with a $1.5 million donation, will target students from both medical and high-tech fields. The program begins this fall. The newspaper interviewed Andy and Dr. Sue Desmond-Hellmann, chancellor of UCSF formerly of Genentech, about the program and their motivations for the effort.